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cerebrovascular events.Background There is emerging evidence that MR-based carotid atherosclerotic plaque assessment identiﬁes high-risk features
associated with cerebrovascular events. However, available data are based on smaller samples with heterogeneous
source populations despite a promising value for noninvasive risk stratiﬁcation.Methods We searched PubMed, EMBASE, and the Cochrane Library through September 2012 for studies that followed
>35 individuals after baseline MRI. Independent observers abstracted information on populations, MR techniques,
outcomes, and study quality. Risk estimates of the presence of IPH for cerebrovascular events were derived
in random effects regression analysis, and causes of heterogeneity were determined in meta-regression
analysis.Results We identiﬁed 8 eligible studies including 689 participants who underwent carotid MRI. The prevalence of IPH at
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allow for sufﬁcient assessment of level of evidence for intervention trials. (J Am Coll Cardiol 2013;62:1081–91)
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1082Recent studies suggest that intra-
plaque hemorrhages (IPH) are
events that could play a major role
in plaque progression and leuko-
cyte inﬁltration, and may also
serve as a measure of risk for the
development of future cardiovas-
cular events (1,2). Thus, the recent
advances in our understanding of
IPH as a critical factor in trig-
gering acute clinical events mighthave important implications for clinical research and, possibly,
future clinical practice.
Until recently, most of our knowledge of the effects of IPH
was based on autopsy studies, carotid or femoral endarter-
ectomy specimens, or animal studies (2,3). However, with the
introduction of high-resolution black-blood magnetic reso-
nance imaging (MRI), noninvasive identiﬁcation of IPH in
the carotid arteries is feasible with good correlation to
histopathology (4–6). Thus, several studies have examined
the effects of IPH on plaque progression and symptoms
(7–9), suggesting a link between IPH and acute cerebrovas-
cular events. This observation was supported by a recentMRI
study in patients with symptomatic carotid stenosis, which
showed that patients with IPH by MRI are more likely to
have spontaneous microembolic activity and cerebral
ischemic embolic lesions (10). Furthermore, American Heart
AssociationMRI-derived type VI carotid plaque is associated
with ipsilateral acute transient ischemic attack (TIA) and
ischemic stroke (11).
To date, multiple longitudinal studies have shown that
IPH, as assessed by MRI, is associated with the occurrence
of cerebrovascular events in symptomatic and in asymp-
tomatic subjects. However, most of these studies were
relatively small, and the absolute numbers of events were
therefore low. Also, there is substantial heterogeneity among
published studies, and the conﬁdence limits of the observed
risk estimates remain wide despite a high relevance for future
intervention trials and cost-effectiveness analyses. Thus, we
pooled available evidence on the prognostic relevance of
carotid MRI in a systematic review and meta-analysis.Methods
Study selection. To identify eligible studies, we searched
PubMed, EMBASE, and the Cochrane Library through
September 2012 using medical subject headings “magnetic
resonance imaging” and “carotid artery plaque” or “athero-
sclerotic plaque” in combination with the text words
“hemorrhage” or “thrombus” and “event” or “stroke” or
“TIA” or “DWI lesion” or “amaurosis fugax” or “symptoms.”
In addition, we obtained expert opinions (C.Y., T.S., M.D.,
F.B.) on whether any potentially relevant study was missed.
Eligible articles were limited to those conducted on human
adults over the age of 18 years. Also, we hand searched all
reference lists of all retrieved original papers and reviewarticles to identify further relevant studies. Finally, we
searched for associated publications of retrieved articles to
obtain the most complete and up-to-date study results.
Inclusion and exclusion criteria. In our analysis, we
included studies that met the following pre-speciﬁed criteria:
follow-up for more than 1 month, 1.5-T MRI scanners,
and detailed assessment of IPH in the carotid arteries at the
baseline examination. IPH was deﬁned as an area within
the carotid plaque with hyperintense signal compared with
the sternocleidomastoid muscle or the normal vessel wall on
T1-weighted fat-suppressed images. Figure 1 shows exam-
ples of MR images of carotid atherosclerotic lesions with and
without IPH. Studies were not included if they did not
provide risk estimates or crude numbers of prevalence and
outcome, or if the occurrence of events was not followed.
Data abstraction and deﬁnitions. Among 208 potentially
eligible studies, we excluded 156 studies based on title and
abstract review. The remaining 52 studies were retrieved for
a more detailed analysis. Of those, 44 studies were excluded
for various reasons, thus 8 studies were available for analysis
(Fig. 2).
Two independent observers (T.S. and H.H.) abstracted
information on all variables listed in Tables 1 and 2, which
included the following endpoints: amaurosis fugax, TIA,
and stroke. Discrepancies between the 2 investigators were
resolved by discussion and re-examination of the corre-
sponding studies with a senior investigator (F.B., M.D., or
M.F.R.) or by contacting the authors of the individual
studies. The total subject number was deﬁned as the number
of participants in whom the risk estimates were derived.
Study quality indicators included the presence or absence of
an endpoint committee, blinded MRI results and blinded
outcome assessment, clear endpoint deﬁnition, clear descrip-
tion of target population, clear deﬁnition of MRI ﬁndings,
adjustment for potential confounders, and exclusion of subjects
after enrollment.
RISK ESTIMATES. To pool the available study results, we
abstracted the hazard ratios (HRs) of the included studies for
the MRI ﬁnding of interest. The most extensively adjusted
HR (with associated 95% conﬁdence interval [CI] derived
from multivariate regression analysis) from each original
study was included to minimize the effect of confounding.
For studies that did not provide multivariate-adjusted HRs,
the univariate risk estimate was included in the analysis.
EVENT RATES. Estimates of absolute risks were derived from
the original studies. From these, all described events were
annualized by using the provided average follow-up time,
which was then summarized by weighting by sample size.
ASSUMPTIONS. In order to pool available evidence, we made
the following assumptions. For 1 study, we derived the per-
taining HR, taking into account the prevalence of MRI
ﬁndings and observed number of events in each group,
assuming a consistent event rate of themean follow-up period.
We also assumed that the ipsilateral risk associated with the
Figure 1 Examples of Carotid Atherosclerotic Plaque With and Without IPH as Derived by MRI
(A) Upper panel: T1-weighted (T1w) fat-suppressed MR images of an 86-year-old patient with acute ischemic stroke ipsilateral to a large atherosclerotic plaque with intraplaque
hemorrhage (IPH) (chevron) in the left ICA; lower panel: T1w fat-suppressed MR images of a 68-year-old asymptomatic patient with long-lasting hypercholesterolemia and large
atherosclerotic plaques without intraplaque hemorrhage in both carotid arteries. (B) In this magniﬁed view of the symptomatic plaque in the left ICA of patient 1, the chevron
points to a region that is hyperintense on both TOF and fat-suppressed black-blood T1w images, consistent with intraplaque hemorrhage. The corresponding area is hypo- to
isointense on black-blood T2w images, indicating acute type I hemorrhage. The contrast-enhanced T1w (CE-T1w) images demonstrate no contrast uptake in this large lesion,
suggestive of a lipid-rich/necrotic core. (C) This magniﬁed view of the asymptomatic plaque in the right CCA shows a large eccentric atherosclerotic plaque, which is isointense
on TOF and T1w images, and hypointense on T2w images, consistent with a large lipid-rich/necrotic core without intraplaque hemorrhage (arrowhead). The lipid-rich/necrotic
core does not show any contrast uptake. Of note, a small contrast-enhancing band is visible on the CE-T1w images, consistent with a thick ﬁbrous cap. CCA ¼ common carotid
artery; CE ¼ contrast enhancement; ECA ¼ external carotid artery; ICA ¼ internal carotid artery; MRI ¼ magnetic resonance imaging; TOF ¼ time-of-ﬂight; VA ¼ vertebral artery.
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1083prevalence of IPH is independent of the contralateral side, an
assumption that all studies relied on. Although this approach
may maximize the number of events, it does not take intoFigure 2 Literature Research and Selection Process of Studies Inclu
Abbreviations as in Figure 1.account the clustered nature of the arteries per subject, which
may result in skewed hazards. For the meta-regression anal-
ysis, the study by Kume et al. (12) was classiﬁed asded in the Analysis
Table 1 Prevalence of Plaque Hemorrhage and Annualized Event Rates
First Author/Year (Ref. #) Region Sample Type N Mean Age (yrs) Men (%)
History of CAD / Ischemic Heart Disease /
Diabetes / Smoker / Hypertension /
Hyperlipidemia / Statins (%) /
Antiplatelets (%)
MRI Scanner
(T)
Exclusion After
Enrollment
Teng et al. 2011 (20) Europe, U.K. TIA, MRI scan within 72 h after
symptoms
42 73.4 60 16.7 / not stated / 9.5 / not stated /
73.8 / not stated / 59.5 / 36
1.5 0
Kurosaki et al. 2011 (14) Asia, Japan TIA, stroke according to TOAST criteria 62 77.8 81 Not stated / 58.1 / 41.9 / not stated /
67.7 / 29.0 / 21.0 / 85.5
1.5 0
Sadat et al. 2010 (21) Europe, U.K. TIA or minor, nondisabling stroke
diagnosed by a consultant stroke
physician
61 74.0 Not stated 14.8 / 34.4 / 9.8 / not stated / 80.3 /
not stated / 100 / 100
1.5 0
Kume et al. 2010 (12) Asia, Japan Carotid plaque and >50% stenosis
by US
165 70.9 81 Not stated / 29.7 / 46.0 / 34.0 / 67.3 /
43.0 / 14.6 / 57.0
1.5 0
Singh et al. 2009 (15) North America, Canada Moderate asymptomatic stenosis
50%–70%
75 74.9 100 Not stated / not stated / 17.3 / 78.7 /
74.7 / 72.0 / 70.7 / 78.7
1.5 1
Altaf et al. 2007 (22) Europe, U.K. Symptomatic patients with 60% to
99% stenosis
66 70.0 70 Not stated / 31.8 / 9.1 / 65.2 / 78.8 /
not stated / 90.1 / 95.5
1.5 10
Altaf et al. 2008 (13) Europe, U.K. Symptomatic patients with mild to
moderate carotid stenosis
(30%–69%)
64 72.7* 80 Not stated / 15.6 / 20.3 / 70.3 / 78.1 /
not stated / 75.0 / 98.4
1.5 9
Takaya et al. 2006 (16) North America, U.S. Asymptomatic, 50%–79% stenosis 154 71.1 82 44 / not stated / 25 / 38 / 75 / 79 /
64 / not stated
1.5 29
*Median age.
CAD ¼ coronary artery disease; MRI ¼ magnetic resonance imaging; TIA ¼ transient ischemic attack; TOAST ¼ Trial of Org 10172 in Acute Stroke Treatment; US ¼ ultrasound.
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Table 2 Study CharacteristicsdResults
First Author/Year
(Ref. #) MRI Finding FU (Months) Endpoint Events TIA Stroke AmF
Multivariable
Adjustment
Teng et al.
2011 (20)
JLH/T 12.8 Stroke, TIA, CEA 11 Not stated Not stated NA No
Kurosaki et al.
2011 (14)
Plaque
hemorrhage
9.1 Stroke, TIA 7 4 3 NA No
Sadat et al.
2010 (21)
Plaque
hemorrhage,
FC rupture
17.1 Stroke, TIA 12 Not stated Not stated No
Kume et al.
2010 (12)
IPH 26 Stroke 29 NA 29 NA No
Singh et al.
2009 (15)
IPH 24.9 Stroke, TIA 6 4 2 NA No
Altaf et al.
2007 (22)
IPH 1.1 Stroke, TIA, AmF 17 9 3 5 Yes, for age,
stenosis,
time between
symptoms and
evaluation,
ischemic heart
disease, CAD
Altaf et al.
2008 (13)
IPH 28 Stroke, TIA, AmF 14 Not stated 5 Not stated No
Takaya et al.
2006 (16)
IPH, thin or
ruptured FC
38.2 Stroke, TIA, AmF 12 4 4 4 No
AmF ¼ amaurosis fugax; CEA ¼ carotid endartherectomy; FC ¼ ﬁbrous cap; FU ¼ follow-up; IPH ¼ intraplaque hemorrhage; JLH ¼ juxtaluminal hemorrhage; T ¼ thrombus; other abbreviations as in Table 1.
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nantly asymptomatic (68%).
The provided median age was assumed to also provide the
mean age in order to pool the age of the overall population
(13). Also, in a subset, the provided mean follow-up time
was assumed to be similar to the median follow-up time,
allowing for pooling of the overall follow-up (12–16).
Data analysis and statistical methods. Data analysis was
performed by an independent investigator (V.H). Descrip-
tive statistics are provided as mean  SD for continuous
parameters, and absolute and relative frequencies for cate-
gorical variables. As a primary objective of the meta-analysis,
we derived the association between the ﬁnding of IPH and
the combined cerebrovascular endpoint.
We used standard statistics to summarize the individual
risk estimates by using the “metafor”-package in R (version
2.10.0; the R Foundation for Statistical Computing, Vienna,
Austria) to pool the natural logarithms (ln) of the HRs,
using a random effects model (restricted maximum-
likelihood estimator). Between-study heterogeneity was
examined using the Q-statistic and the I2 statistic (17).
Publication bias was assessed using plots of study results
against precision of the study (funnel plots). Symmetry of
the funnel plots was tested using the methods developed by
Egger et al. (18) and Begg and Mazumdar (19).
A meta-regression analysis was performed to identify
sources of the detected high degree of heterogeneity of the risk
estimates. The following pre-speciﬁed variables were
analyzed: 1) symptomatic and asymptomatic subjects; 2)
subjects older or younger than the median age (73 years); 3)
enrollment of predominantly male subjects (median: 81%
males); 4) higher prevalence of diabetes mellitus (median:18% diabetic patients); 5) higher prevalence of statin therapy
(median: 67% on statin therapy); 6)multisequence and single-
sequence MRI; 7) subjects with high-grade stenosis versus
studies that did not include subjects with high-grade stenosis;
8) symptomatic subjects and time between symptoms
and MRI of <72 h versus <6 months; 9) Asian versus U.S./
European studies; 10) retrospective versus prospective study
design; 11) small versus large sample size (number of subjects
> or 70); 12) studies with low versus good study quality
(quality score<3.5 vs.<3.5); and 13) studies that did and did
not adjust for confounders. To further investigate effect
modiﬁcation, for each of the subgroups, a HR was calculated.
A p value of 0.1 was selected to indicate absence of signif-
icant heterogeneity of the estimates.
All analysis was performed using R (version 2.10.0), and
a p value <0.05 was considered to indicate statistical
signiﬁcance.
Results
Overall, we identiﬁed 8 studies that met the criteria and
were included in the analysis (12–16,20–22); study details
are provided in Tables 1 and 2. The majority of studies were
conducted in the United States and Europe (2 [25%] and 4
[50%], respectively), whereas 2 (25%) studies were per-
formed in Asia. One study (12.5%) was designed as
a multicenter trial enrolling at 2 sites (12), and the majority
was prospective in design, with only 2 (25%) studies of
a retrospective nature (14,15).
The study population consisted of 689 subjects with 712
analyzed carotid arteries, predominantly older men (73.1 
2.2 years of age, and 79% men), who presented with TIA
Saam et al. JACC Vol. 62, No. 12, 2013
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1086(62.5%) or were asymptomatic with known moderate carotid
stenosis as determined by sonography (12,15,16). The prev-
alence of diabetes, hypertension, hyperlipidemia, smoking,
and prior history of cardiovascular disease was high (24%,
74%, 56%, 57%, and 30.7%, respectively). Consistently, the
majority of subjects were treated medically (statin treatment,
62.0%; antiplatelet treatment, 72.0%).
All subjects were examined using a 1.5-T MR scanner. A
multisequence approach was applied in 4 (50%) and elec-
trocardiogram gating in 2 (25%) studies. The detected
degree of carotid stenosis was moderate in the majority of
studies (in 62.5% of studies, patients with 80% were not
included 80% stenosis). After the MR examination, 6.3% of
subjects, on average, were excluded per study (range, 0% to
15.8%) (16) for various causes, including impaired image
quality in all cases (16), claustrophobia in 88.8% (13), or
withdrawal from participation in 70% of excluded cases (22).
On average, the follow-up time was 19.73 months, ranging
from 1.12 months (22) to 38.2 months (16). Over the follow-
up period, a total of 108 outcome events were observed,
consistent with a high event rate of 15.5%; details of the
outcome events by study are provided in Table 2. A composite
endpoint was applied in all but 1 study (87.5%) (12).
Plaque hemorrhage and cardiovascular events. Similar to
that of the overall population, the risk associated with IPH
on MRI was derived from 8 studies consisting of 689
patients. Based on a total of 108 outcome events, the
combined estimated HR was 5.69 (95% CI: 2.98 to 10.87)Figure 3 Forrest Plot Showing Single Studies Included in the Analys
Horizontal lines represent 95% conﬁdence intervals (CI). The rectangles represent the po
study in the meta-analysis. The diamond represents the summary estimate (size of the di
risk. HR ¼ hazard ratio; neg ¼ negative; pos ¼ positive; other abbreviations as in Figure(Figs. 3 and 4), indicating an approximately 5.7-fold higher
risk among subjects with any plaque hemorrhage as detected
by MRI compared with subjects without any evidence
of plaque hemorrhage. The random effects estimate for
impact of a positive MRI was 1.74 (95% CI: 1.09 to 2.39)
with a borderline test for heterogeneity (p ¼ 0.072), indi-
cating signiﬁcant between-study heterogeneity (Q-statistic,
p< 0.001), and according to the I2 test, 32% of the variability
could be explained by between-study heterogeneity.
Although the funnel plot revealed no statistical sign of
asymmetry (z ¼ 1.34, p ¼ 0.18), there was a moderate visual
publication bias due to missing studies with small sample
sizes and moderate risk estimates (Fig. 5).
The prevalence of a positive MRI for IPH was high
(average, 49.0%), and among subjects with a positive MRI,
30.6% experienced an event (Table 3). The weighted
annualized event rate in subjects with a positive MRI was
17.7%. Conversely, 51.0% had a negative MRI associated
with an average event rate of 4.1%. The weighted annualized
event rate in subjects with a negative MRI was 2.4%.
Heterogeneity analysis. Given the detected heterogeneity
of the pooled risk estimates, we identiﬁed the proportion of
male subjects in the study population, symptom status
(Fig. 4), and sample size as potential sources of heteroge-
neity (Table 4). There was no signiﬁcant difference in the
risk estimate for IPH by MRI according to population age,
proportion of diabetes mellitus, current statin medication,
MRI technology applied, degree of stenosis, time of MRI inis for the Risk Associated With the Presence of IPH
int estimate, and the size of the rectangle is proportional to the weight given to each
amond ¼ 95% CI). The dashed vertical line represents the reference of no increased
1.
Figure 4
Forrest Plot Demonstrating Asymptomatic and Symptomatic Studies Included in the Analysis for the Risk Associated
With the Presence of IPH
Horizontal lines represent 95% conﬁdence intervals (CI). The rectangles represent the point estimate, and the size of the rectangle is proportional to the weight given to each
study in the meta-analysis. The diamond represents the summary estimate (size of the diamond ¼ 95% CI). The dashed vertical line represents the reference of no increased
risk. (A) Asymptomatic studies and (B) symptomatic studies. Abbreviations as in Figures 1 and 3.
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1087relation to symptoms, region, design, included endpoints, or
adjustment (all p > 0.1).
Studies that comprise a majority of male patients (81%)
observed higher risk estimates for occurrence of events in
patients with IPH (HR: 15.47, 95% CI: 5.89 to 40.65),
whereas studies that included predominantly female patients
observed a signiﬁcantly lower risk (HR: 3.50, 95% CI: 2.59
to 4.73) (p ¼ 0.004). We also found that the observed risk
associated with IPH in studies enrolling symptomatic
subjects was signiﬁcantly higher as compared with studies
that enrolled asymptomatic studies (HR: 11.71, 95%
CI: 5.17 to 26.48 vs. HR: 3.50, 95% CI: 2.59 to 4.73,
p ¼ 0.0065 for symptomatic and asymptomatic subjects,
respectively) (Fig. 4). Finally, we observed that studies that
were characterized by a small sample size (N < 70) reported
higher risk estimates as compared with studies with larger
sample sizes (p < 0.0065). Speciﬁcally, although smaller
studies reported a pooled hazard ratio of 11.7 (95% CI: 5.18
to 26.47), larger studies reported a risk associated with
plaque hemorrhage detected by MRI of 3.5-fold (HR: 3.50,
95% CI: 2.59 to 4.73).Study quality. The average study quality score was 3.5,
ranging from 2 (20) to 5 (13). Although all studies provided
clear deﬁnitions of the study population and MR ﬁndings,
no study had an endpoint committee. In the majority of
studies, a blinded analysis of MR ﬁndings was performed
(12,13,15,16), whereas only 1 study explicitly stated blinded
outcome assessment (13). Fifty percent of the studies
provided clear deﬁnitions of endpoints (13,14,16,21). Only
1 study adjusted for potential confounders (13), and only 1
study did not exclude patients after they were enrolled (21).
Discussion
With the present analysis, we systematically evaluated and
pooled available evidence on the predictive value of IPH by
MRI for the occurrence of cerebrovascular events. Although
the pre-existing literature shows little controversy regarding
the link between IPH and cerebrovascular events, our results
indicate that the available data are very heterogeneous and
limited to smaller sample-size trials of symptomatic and
asymptomatic subjects. Despite these identiﬁed sources of
Figure 5 Funnel Plot Assessing Publication Bias
Although there was no statistical sign of asymmetry, the funnel plot demonstrates
moderate visual publication bias due to missing studies with small sample size
and moderate risk estimates.
Saam et al. JACC Vol. 62, No. 12, 2013
Predictive Value of Plaque Hemorrhage September 17, 2013:1081–91
1088heterogeneity, the predictive value of IPH is strong, with an
approximately 6-fold higher risk for events. Thus, our data
are particularly relevant to harmonize reporting standards for
ongoing or future studies and to provide risk estimates
necessary as a baseline for prospective randomized trials
applying risk modiﬁcation on the basis of evaluation by
MRI.
MRI has triggered the expectation that imaging
features, such as IPHddeﬁned as the presence of T1
hyperintensitiesdrepresent imaging biomarkers for high risk
and thus allow the determination ofwhomay be considered for
invasive treatment strategies or who may beneﬁt from
conservativemanagement. Findings of ourmeta-analysis show
that symptomatic patients with carotid stenosis >50% and
IPHhave a particularly high risk of a recurrent event.However,Table 3 Prevalence of MRI Findings of Any Plaque Hemorrhage
All
First Author/Year (Ref. #) N
Events
(N)
Annualized
Event Rate Prevalenc
Teng et al. 2011 (20) 42 11 24.5 50.0
Kurosaki et al. 2011 (14) 62 7 14.8 48.4
Sadat et al. 2010 (21) 61 12 13.3 49.0
Kume et al. 2010 (12) 165 29 8.1 52.7
Singh et al. 2009 (15) 98 6 3.8 63.3
Altaf et al. 2007 (22) 66 17 22.9* 33.3
Altaf et al. 2008 (13) 64 14 8.2 39.0
Takaya et al. 2006 (16) 154 12 2.4 72.0
Weighted* 9.89
Values are % except as noted. The prevalence of MRI ﬁndings of any plaque hemorrhage, number of e
derived from crude event numbers provided in the source publication. *Averaged annualized event rate
MRI ¼ magnetic resonance imaging.our results indicate that this ﬁnding may currently not serve as
a basis for clinical decision making, given the detected degree
of heterogeneity of study quality and the limited level of
evidence. By contrast, our data raise the need and rationale
for future larger-scale trials to provide ﬁnal evidence on the
value of IPH evaluation by MRI.
The overall study quality we detected was moderate but
ranged from low to good. Although early studies on the
potential technology are highly relevant to trigger future
developments, more rigorously designed and analyzed large-
scale studies are warranted to provide the sufﬁcient level of
evidence for clinical decision making. This is particularly
relevant with respect to the following aspects:
1. A more homogeneous deﬁnition of IPH is warranted
and would allow for adequate comparison of different
studies. Predominantly, in our analysis, we found IPH
deﬁned as hyperintense signal on T1-weighted fat-
suppressed images as compared with the normal
vessel wall or the sternocleidomastoid muscle in the
literature, which should be applied to future trials.
2. Almost all of the studies failed to adjust for potential
confounders. Although we did not detect any signif-
icant interaction with respect to adjustment, given the
limited sample (Table 4), this certainly introduces the
risk for false-positive ﬁndings. Thus, future studies are
strongly advised to account for other parameters that
may explain the observed effects by applying stan-
dardized advanced methods such as adjustment,
matching, or stratiﬁed analysis.
3. In a number of studies, it remained unclear how many
subjects were excluded after enrollment and imaging,
and if excluded, for which reason. This may poten-
tially bias the observed estimates signiﬁcantly. As
such, consistent with current recommendations (23),
utilization of a study ﬂowchart would demonstrate the
presence of selection bias more evidently.
4. Our results indicate that the absolute and relative
numbers of events by test result were inconsistently
reported. For upcoming trials, it will be of criticalMRI Positive MRI Negative
e Events
Annualized
Event Rate Prevalence Events
Annualized
Event Rate
52.4 49.0 50.0 0 0
18.8 24.7 51.6 3.3 4.4
d d 51.0 d d
28.2 13.0 47.3 8.1 3.7
16.7 8.0 36.7 0 0
34.1 d 66.7 9.1 d
33.3 14.7 61.0 4.0 1.7
d d 28 d 0
17.71 2.43
vents, and annualized event rates among all subjects with MRI positive and negative ﬁndings are
s (%) are weighted by sample size.
Table 4 Random Effects Meta-Analysis
Studies
(N)
Participants
(N) Hazard Ratio (95% CI) p Value*
Average age
>73 yrs* 4 240 7.26 (2.58–20.45) 0.6145
73 yrs 4 449 4.95 (1.69–14.47)
Proportion of males
81%* 4 456 15.47 (5.89–40.65) 0.0040
<81% 3 172 3.50 (2.59–4.73)
Diabetes
>18%* 4 454 4.27 (1.44–12.65) 0.4113
18% 4 235 7.89 (2.95–21.11)
Current statin medication
>67%* 4 266 6.04 (2.24–16.31) 0.9864
67% 4 423 5.96 (1.99–17.85)
Presentation
Asymptomatic 3 394 3.50 (2.59–4.73) 0.0065
Symptomatic 5 295 11.71 (5.17–26.48)
MRI technology
Multisequence 4 422 5.63 (1.96–16.21) 0.8650
Single sequence 4 267 6.41 (2.27–18.05)
Degree of stenosis
High grade included 3 189 8.46 (2.59–27.63) 0.4197
High grade not included 5 500 4.77 (2.29–9.94)
Time MRI to symptoms
<72 h 2 104 22.61 (5.19–98.48) 0.2926
<6 months 3 191 8.75 (3.28–23.31)
Region code
Asia 2 227 2.59 (0.61–11.07) 0.2304
Europe, U.S. 6 462 7.03 (3.36–14.70)
Design
Retrospective 2 137 4.40 (1.24–15.60) 0.5727
Prospective 6 552 6.85 (2.87–16.36)
Sample size
Small (N < 70) 5 295 11.71 (5.18–26.47) 0.0065
Large (N > 70) 3 394 3.50 (2.59–4.73)
Study quality
Sum 3.5* 4 344 4.63 (1.95–11.03) 0.4833
Sum >3.5* 4 345 7.40 (2.78–19.65)
Adjustment
Not adjusted 7 623 3.83 (2.83–5.17) 0.1532
Adjusted 1 66 13.00 (2.50–67.70)
The random effects meta-analysis was performed on the relationship between MRI ﬁnding of plaque hemorrhage on a combined cerebrovascular
event endpoint, stratiﬁed according to potential sources of heterogeneity. *For difference.
CI ¼ conﬁdence interval; MRI ¼ magnetic resonance imaging.
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absolute numbers of events in the group of MR
positive and negative patients.
5. Finally, there is inconsistency among available studies
with respect to the reported number of vessels per
subject. We found that these discrepancies substan-
tially hampered the pooling of derived risk estimates
because the number of control cases has an impact on
the relative risks. We suggest that the risks for both
carotid artery ﬁndings be reported adequately.
Notably, despite these aspects, our results also conﬁrm the
great potential of assessment of IPH by MRI, with an
approximately 5.6-fold higher risk for events.There is still an ongoing controversy over which T1-
weighted sequence is best suited to detect relevant IPH.
However, our analysis indicated that therewas no difference in
the observed risk between studies that used a multisequence
strategy as compared with studies with fat-suppressed T1-
weighted sequence acquisition (p ¼ 0.87). Although there is
a presumed improvement in visualization of plaque compo-
nents in the near future with the development of new 3-
dimensional sequences and higher ﬁeld strengths (24),
a baseline analysis with a simple fat-suppressed T1-weighted
sequence analysis should be speciﬁcally reported.
Interestingly, we found that the associated risk of IPH is
higher among studies including predominantly male subjects
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1090(HR: 15.5 vs. 3.5). It is well established that women with
ischemic stroke have a lower risk of ipsilateral ischemic
stroke on medical treatment and a higher operative risk than
do men. The same patterns were also shown in a large trial
of carotid endarterectomy for asymptomatic stenosis (25).
Consequently, carotid endarterectomy for asymptomatic
stenosis is beneﬁcial in men, but not in women. Similarly,
a recent meta-analysis (26) showed that carotid endarterec-
tomy is clearly beneﬁcial in women with 70% or more
symptomatic stenosis, but not in those with 50% to 69%
stenosis. Therefore, identifying women with symptomatic
carotid stenosis with a particularly high stroke risk might be
of importance because carotid endarterectomy might prove
to be beneﬁcial for these selected individuals. Interestingly, it
has been shown that women with IPH and severe stenosis
have a similar risk as men have for recurrent cerebrovascular
events (27). Further, sex-speciﬁc research in randomized
controlled trials is required to evaluate the potential beneﬁt
of IPH detection by MRI in speciﬁc patient populations in
both men and women.
We observed that smaller sample-size studies were asso-
ciated with higher risk estimates as compared with larger
samples. Although this ﬁnding is known from previous
analysis representing publication bias, it needs to be noted
that despite no statistical evidence of publication bias, visual
inspection of the funnel plot demonstrated moderate
publication bias due to missing studies with small sample
sizes and moderate risk estimates. Thus, further smaller
studies will be necessary to exclude the remaining probability
of a false-positive observation.
We found an absolute annualized event rate of 17.71% in
subjects with a positive MR ﬁnding for IPH, whereas
subjects with a negative MR ﬁnding for IPH incurred
a 2.43% annualized event rate. Therefore, similar to the
relative risk, the absolute risk associated with a positive MRI
ﬁnding for IPH is relatively high. That the event rate in
subjects without IPH is not zero can certainly be partially
attributed to the fact that there are a number of other causes
of stroke, such as cardiac emboli and small vessel disease
(28), but the event rate also indicates risks dependent of the
presence of other high-risk plaque features well known from
coronary atherosclerosis (29). The degree of carotid stenosis
is a well-known risk factor for cerebrovascular events, and
together with the symptomatology of the patient, forms the
current basis for clinical decision making (30). In the
analyzed studies, the highest event rate and shortest time to
event were observed in patients with IPH and additional
high-grade stenoses (22). In highly stenotic segments,
even the formation of small additional thrombi, which
might go unnoticed in less obstructed vessels, can lead to
complete occlusion of the vessel with subsequent events.
Also, several other MRI-based plaque features, such as
a thin or ruptured ﬁbrous cap, and plaques with a large lipid-
rich or necrotic core, have been associated with cerebrovas-
cular events in prospective studies (16,31). However, IPH
can be easily visualized using 1 single MRI sequence,whereas multisequence protocols are needed in order to
identify the status of the ﬁbrous cap (5,32). Our included
populations consisted of symptomatic and asymptomatic
subjects. Findings of the meta-regression showed that
symptomatic patients with carotid stenosis and IPH have
a particularly high risk of a recurrent event and, as a conse-
quence, might beneﬁt from early interventions. We were not
able to analyze the event rates of symptomatic patients with
IPH and <50% stenosis, given the very limited data,
although there is increasing evidence that such lesions might
play a role in the pathogenesis of symptoms in patients with
cryptogenic stroke (33). Several ongoing prospective MRI
trials, such as the CAPIAS trial (Carotid Plaque Imaging in
Acute Stroke, NCT01284933), are investigating the con-
sequences of such lesions on the occurrence of cerebrovas-
cular events in patients with acute ischemic stroke and
without signiﬁcant carotid artery stenosis.
Study limitations. A general limitation of this analytic
technique is that the validity of the results depends on each
single original study. Our meta-analytic approach relied on
combining the aggregate HRs and associated 95% CIs from
each trial using random effects modeling, accounting for
heterogeneity among the original studies. However, besides
pooling the result, it was a pre-deﬁned objective of the
present study to also identify strengths and weaknesses of
current literature on IPH in a systematic review. Also, the
number of potential confounders we investigated in the
meta-regression was high, with the risk of false-positive
ﬁndings. Importantly, our results were derived from
cohorts enrolling subjects with known carotid artery disease
with >30% stenosis. Thus, our results apply exclusively to
patients with >30% carotid stenosis and cannot be gener-
alized to a population with <30% stenosis. The overall HR
of 5.69 needs to be interpreted with caution because it
summarizes data from both symptomatic and asymptomatic
patient populations. Although it may introduce bias to
combine both populations, given the markedly different pre-
test probabilities of events in the 2 groups, we report and
highlight the individual HRs of 3.50 for asymptomatic and
11.71 for symptomatic populations, which should be
considered for the design of future studies. We were not able
to analyze the incremental predictive value of IPH beyond
other imaging markers of cardiovascular risk, such as coro-
nary calcium scoring or intima-media thickness measure-
ments, as none of the studies compared the prognostic value
of other imaging modalities.
Conclusions
Our results suggest that despite a large degree of detected
heterogeneity of the published studies, the presence of IPH
by MRI is associated with an approximately 5.6-fold higher
risk for cerebrovascular events as compared with the risk for
subjects without IPH. However, although this ﬁnding cannot
serve as a rationale for widespread application of MRI in a
clinical context in subjects referred for neurological work-up,
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1091it forms the basis for larger-scale trials and cost-effectiveness
analysis with a special emphasis on harmonized design and
reporting. Thus, further work and intervention trials will be
necessary to ﬁnally determine whether MR-based identiﬁ-
cation of plaque hemorrhage might consistently risk stratify
patients into those who beneﬁt from conservative versus
interventional therapy.
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